Insulin Access for All Act of 2021

To amend titles XVIII and XIX of the Social Security Act to eliminate cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program. 1. Short title This Act may be cited as the Insulin Access for All Act of 2021 2. Eliminating cost sharing with respect to coverage of insulin as a covered part D drug under the Medicare program or as a covered outpatient drug under the Medicaid program (a) Medicare (1) Elimination of cost sharing for insulin and certain associated medical supplies furnished to part D eligible individuals Section 1860D–2 of the Social Security Act ( 42 U.S.C. 1395w–102 (A) in subsection (b)— (i) in paragraph (1)(A), by striking The coverage Subject to paragraph (8), the coverage (ii) in paragraph (2)— (I) in subparagraph (A), by inserting after Subject to subparagraphs (C) and (D) and paragraph (8) (II) in subparagraph (C)(i), by striking paragraph (4) paragraphs (4) and (8) (III) in subparagraph (D)(i), by striking paragraph (4) paragraphs (4) and (8) (iii) in paragraph (4)(A)(i), by striking The coverage Subject to paragraph (8), the coverage (iv) by adding at the end the following new paragraph: (8) Elimination of cost sharing for certain covered part D drugs The coverage does not impose any deductible, copayment, coinsurance, or other cost sharing for insulin (as described in subparagraph (B) of subsection (e)(1)) or medical supplies associated with the injection of insulin (as described in such subparagraph). ; and (B) in subsection (c), by adding at the end the following new paragraph: (4) Same elimination of cost sharing for certain covered part D drugs The coverage is in accordance with subsection (b)(8). . (2) Elimination of cost sharing for insulin and certain associated medical supplies furnished to part D eligible individuals who are subsidy eligible individuals Section 1860D–14(a) of the Social Security Act ( 42 U.S.C. 1395w–114(a) (A) in paragraph (1)— (i) in subparagraph (D)— (I) in clause (ii), by striking In the case of Subject to subparagraph (F), in the case of (II) in clause (iii), by striking In the case of Subject to subparagraph (F), in the case of (ii) by adding at the end the following new subparagraph: (F) Elimination of cost sharing for certain covered part D drugs Coverage that is in accordance with section 1860D–2(b)(8). ; and (B) in paragraph (2)— (i) in subparagraph (D), by striking The substitution Subject to subparagraph (F), the substitution (ii) in subparagraph (E), by inserting after Subject to subparagraph (F) and (iii) by adding at the end the following new subparagraph: (F) Elimination of cost sharing for certain covered part D drugs Coverage that is in accordance with section 1860D–2(b)(8). . (3) Applicability The amendments made by this subsection shall apply with respect to insulin, and medical supplies associated with the injection of insulin, furnished on or after January 1, 2022. (b) Medicaid (1) In general Section 1916 of the Social Security Act ( 42 U.S.C. 1396o (A) in subsection (a)(2)— (i) in subparagraph (H), by striking or (ii) in subparagraph (I), by striking ; and , or (iii) by adding at the end the following new subparagraph: (J) insulin furnished as a covered outpatient drug (as defined in section 1927(k)(2)) and medical supplies associated with the injection of such insulin; and ; and (B) in subsection (b)(2)— (i) in subparagraph (H), by striking or (ii) in subparagraph (I), by striking ; and , or (iii) by adding at the end the following new subparagraph: (J) insulin furnished as a covered outpatient drug (as defined in section 1927(k)(2)) and medical supplies associated with the injection of such insulin; and . (2) Alternative cost sharing limitation Section 1916A(c)(2) of the Social Security Act ( 42 U.S.C. 1396o–1(c)(2) (D) Nonapplicability of cost sharing to insulin In no case may the cost sharing under paragraph (1)(A) apply with respect to insulin furnished as a covered outpatient drug (as defined in section 1927(k)(2)) and medical supplies associated with the injection of such insulin. . (3) Effective date (A) In general Subject to subparagraph (B), the amendments made by this subsection shall apply with respect to covered outpatient drugs furnished on or after January 1, 2022. (B) Exception for State legislation In the case of a State plan under title XIX of the Social Security Act ( 42 U.S.C. 1396 et seq.

Summary: Insulin Access for All Act of 2021 This bill prohibits cost-sharing (e.g., copayments) under Medicaid and the Medicare prescription drug benefit for insulin and associated medical supplies.